Skip to main content

Want a detailed portfolio tracker?

PHAXIAM Therapeutics SA ADR (PHXM) P/E (2023 - 2026)

PHAXIAM Therapeutics SA ADR (PHXM) P/E from Jun 29, 2023 to Jul 21, 2026. The TTM PHAXIAM Therapeutics SA ADR (PHXM) P/E is -1.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PHAXIAM Therapeutics SA ADR (PHXM)

YearP/EChange
2026-1.63+825.77%
2023-0.18N/A

Comparison PHAXIAM Therapeutics SA ADR (PHXM) P/E with competitors

PHAXIAM Therapeutics SA ADR (PHXM) P/E is -1.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.10%
NBYStablecoin Development Corp0.00-100.26%
ENLVEnlivex Ltd0.07-104.58%
FGENFibroGen Inc0.24-114.69%
CHRSCoherus Biosciences Inc0.85-151.92%
FBIOFortress Biotech Inc0.95-158.07%
ORMPOramed Pharmaceuticals Inc1.50-191.97%
AGENAgenus Inc3.01-284.16%
INVAInnoviva Inc3.15-292.99%
VXRTVaxart Inc3.55-317.21%
CRMDCorMedix Inc3.63-322.02%
CVACCureVac N.V.4.45-372.03%
GLPGGalapagos NV4.86-397.31%
SRPTSarepta Therapeutics Inc4.88-398.73%
ABEOAbeona Therapeutics Inc5.39-429.66%
ABUSArbutus Biopharma Corp5.60-442.39%
ZVRAZevra Therapeutics Inc5.89-460.24%
SPROSpero Therapeutics Inc6.23-481.12%
CGENCompugen Ltd6.31-486.35%
RIGLRigel Pharmaceuticals6.87-520.50%
SLXNSilexion Therapeutics Corp7.30-546.44%
OMEROmeros Corporation9.26-666.54%
AUPHAurinia Pharmaceuticals Inc9.58-686.50%
PLXProtalix BioTherapeutics Inc10.89-766.42%
ACADAcadia Pharmaceuticals Inc11.73-817.67%
TBPHTheravance Biopharma Inc12.26-850.32%
ADMAAdma Biologics Inc12.42-859.86%
HRMYHarmony Biosciences Holdings Inc13.82-945.66%
SABSSAB Biotherapeutics Inc14.14-964.99%
NAGENiagen Bioscience Inc14.82-1006.72%
INCYIncyte Corp15.82-1068.18%
REGNRegeneron Pharmaceuticals Inc15.86-1070.27%
PBYIPuma Biotechnology Inc17.32-1159.55%
CPRXCatalyst Pharmaceuticals Inc17.44-1167.11%
EXELExelixis Inc17.54-1173.15%
TGTXTG Therapeutics Inc18.97-1260.53%
MDXGMimedx Group Inc20.55-1357.61%
XOMAXOMA Royalty Corp22.87-1499.74%
ARGXArgen X SE24.30-1586.83%
CTMXCytomX Therapeutics Inc24.82-1618.84%
XOMAOXOMA Royalty Corp25.34-1650.89%
HALOHalozyme Therapeutics Inc25.62-1667.95%
XOMAPXOMA Royalty Corp25.67-1670.79%
VRTXVertex Pharmaceuticals Inc27.99-1813.04%
RPRXRoyalty Pharma plc - Class A28.69-1855.43%
SLNOSoleno Therapeutics Inc29.02-1875.49%
ASNDAscendis Pharma A/S30.09-1940.98%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2419.89%
APLSApellis Pharmaceuticals Inc39.02-2487.77%
BMRNBiomarin Pharmaceutical Inc42.21-2683.01%
KRYSKrystal Biotech Inc45.34-2874.64%
ONCBeiGene Ltd69.54-4355.29%
TECHBio-Techne Corp101.96-6338.99%
VCELVericel Corp109.92-6826.26%
ALNYAlnylam Pharmaceuticals Inc117.96-7318.47%
GMABGenmab140.29-8684.61%
TLXTelix Pharmaceuticals Ltd162.15-10022.39%
CORTCorcept Therapeutics Inc212.86-13125.09%